234 related articles for article (PubMed ID: 29179185)
1. VEGF-A/Neuropilin 1 Pathway Confers Cancer Stemness via Activating Wnt/β-Catenin Axis in Breast Cancer Cells.
Zhang L; Wang H; Li C; Zhao Y; Wu L; Du X; Han Z
Cell Physiol Biochem; 2017; 44(3):1251-1262. PubMed ID: 29179185
[TBL] [Abstract][Full Text] [Related]
2. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
[TBL] [Abstract][Full Text] [Related]
3. RNA binding protein Lin28B confers gastric cancer cells stemness via directly binding to NRP-1.
Wang X; Hu H; Liu H
Biomed Pharmacother; 2018 Aug; 104():383-389. PubMed ID: 29787985
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis.
Shukla S; Sinha S; Khan S; Kumar S; Singh K; Mitra K; Maurya R; Meeran SM
Sci Rep; 2016 Feb; 6():21860. PubMed ID: 26905250
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
6. Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells.
Ciccone V; Terzuoli E; Donnini S; Giachetti A; Morbidelli L; Ziche M
J Exp Clin Cancer Res; 2018 Dec; 37(1):311. PubMed ID: 30541574
[TBL] [Abstract][Full Text] [Related]
7. HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.
Zhang Y; Zhang Q; Cao Z; Huang Y; Cheng S; Pang D
Cell Physiol Biochem; 2018; 46(4):1737-1747. PubMed ID: 29698974
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 promotes the oncogenic Tenascin-C/integrin β3 pathway and modulates chemoresistance in breast cancer cells.
Naik A; Al-Yahyaee A; Abdullah N; Sam JE; Al-Zeheimi N; Yaish MW; Adham SA
BMC Cancer; 2018 May; 18(1):533. PubMed ID: 29728077
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
[TBL] [Abstract][Full Text] [Related]
11. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
12. Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.
Jiang L; Yin M; Wei X; Liu J; Wang X; Niu C; Kang X; Xu J; Zhou Z; Sun S; Wang X; Zheng X; Duan S; Yao K; Qian R; Sun N; Chen A; Wang R; Zhang J; Chen S; Meng D
Circ Res; 2015 Jul; 117(4):364-375. PubMed ID: 26123998
[TBL] [Abstract][Full Text] [Related]
13. VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression.
Cao Y; E G; Wang E; Pal K; Dutta SK; Bar-Sagi D; Mukhopadhyay D
Cancer Res; 2012 Aug; 72(16):3912-8. PubMed ID: 22693250
[TBL] [Abstract][Full Text] [Related]
14. FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.
Cheng S; Huang Y; Lou C; He Y; Zhang Y; Zhang Q
Cancer Biol Ther; 2019; 20(3):328-337. PubMed ID: 30336071
[TBL] [Abstract][Full Text] [Related]
15. rESWT promoted angiogenesis via Bach1/Wnt/β-catenin signaling pathway.
Yang F; Guo J; Kang N; Yu X; Ma Y
Sci Rep; 2024 May; 14(1):11733. PubMed ID: 38777838
[TBL] [Abstract][Full Text] [Related]
16. Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts.
Zhu C; Cheng KW; Ouyang N; Huang L; Sun Y; Constantinides P; Rigas B
Stem Cells; 2012 Oct; 30(10):2065-75. PubMed ID: 22653497
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of neuropilin-1 suppresses invasion, angiogenesis, and increases the chemosensitivity to doxorubicin in osteosarcoma cells - an in vitro study.
Yue B; Ma JF; Yao G; Yang MD; Cheng H; Liu GY
Eur Rev Med Pharmacol Sci; 2014; 18(12):1735-41. PubMed ID: 24992616
[TBL] [Abstract][Full Text] [Related]
18. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
[TBL] [Abstract][Full Text] [Related]
19. RNA binding protein PUM2 promotes the stemness of breast cancer cells via competitively binding to neuropilin-1 (NRP-1) mRNA with miR-376a.
Zhang L; Chen Y; Li C; Liu J; Ren H; Li L; Zheng X; Wang H; Han Z
Biomed Pharmacother; 2019 Jun; 114():108772. PubMed ID: 30909144
[TBL] [Abstract][Full Text] [Related]
20. NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival.
Grun D; Adhikary G; Eckert RL
Mol Carcinog; 2019 Apr; 58(4):488-499. PubMed ID: 30456845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]